Fall 2022

Patient Reported Pain Interference Following Chemotherapy among Adults with Breast Cancer

The PRO-PM assesses pain interference among adult women with breast cancer entering survivorship after completion of chemotherapy administered with curative intent. Pain interference is assessed using the PROMIS Pain Interference 4a scale administered at baseline (prior to chemotherapy) and at follow-up (about three months following completion of chemotherapy). The measure is risk-adjusted.

CBE ID

3718

Percentage of vulnerable adults admitted to ICU who survive at least 48 hours who have their care preferences documented within 48 hours OR documentation as to why this was not done.

CBE ID

1626

The PSWR measure tracks the number of prevalent dialysis patients in a practitioner (inclusive of physicians and advanced practice providers) group who are under the age of 75 and were listed on the kidney or kidney-pancreas transplant waitlist or received a living donor transplant. For each practitioner group, the Prevalent Standardized Waitlist Ratio (PSWR) is calculated to compare the observed number of waitlist events in a practitioner group to its expected number of waitlist events.

CBE ID

3719

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

CBE ID

0389e

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

CBE ID

0389

The measure captures the ratio of the number of patients, who are attributed to a clinician or practice, with a diagnosis of any stage of cognitive impairment over the expected number of cases based on a predictive model. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.

CBE ID

3729

Ratio of the number of patients 65 and older diagnosed with dementia attributed to a clinician or practice over the number of cases predicted based on the demographic profile of that clinician or practice. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.

CBE ID

3672

Ratio of the number of patients 65 and older diagnosed with mild cognitive impairment attributed to a clinician or practice over the number predicted based on the demographic profile of that clinician or practice. Once the clinician’s or practice’s O/E ratio (i.e., ratio of the observed and expected rates) is calculated, a computation of its associated standard error (SE) can be used to draw inference whether the O/E ratio is significantly different from 1 or not.

CBE ID

3707